Advertisement

Topics

CANTOS: Dousing the Fire Within to Reduce CVD

07:33 EDT 7 Aug 2017 | Medscape

Dr O’Donoghue discusses preliminary results from the CANTOS trial of canakinumab, a unique anti-inflammatory agent which represents a new pathway for treating cardiovascular disease.
theheart.org on Medscape

Original Article: CANTOS: Dousing the Fire Within to Reduce CVD

NEXT ARTICLE

More From BioPortfolio on "CANTOS: Dousing the Fire Within to Reduce CVD"

Quick Search
Advertisement
 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...